Search results
Added:
3 months ago
Source:
Radcliffe CVRM
A pragmatic, scalable approach to obesity implemented in primary care has the potential to curtail population weight gain, according to findings from the PATHWEIGH trial. The study found that a multi-component care process successfully mitigated the weight gain observed with usual care and increased the likelihood of patients receiving weight-related treatment.¹The PATHWEIGH intervention…
View more
Start date:
Jul 12, 2025
End date:
Jul 15, 2025
ENDO 2025 will take place on July 12th to 15th 2025 in San Francisco at the Moscone Convention Center. ENDO 2025 will host over 7,000 attendees with nearly 2,500 abstracts, and the sessions are set to cover obesity, diabetes, endocrine-disrupting chemicals, growth hormones, thyroid conditions, reproductive health, endocrine cancers, and much more.
View more
Understanding the Role of GLP-1 RAs in the Treatment of HF
Author(s):
Giovanni Battista Bonfioli
,
Matteo Pagnesi
,
Daniela Tomasoni
,
et al
Added:
8 months ago
Review Article
Antonio P Arenas de Larriva
Author
Jason Halford
Research Area(s) / Expertise:
Author
Expertise
Sabine Steiner
Author
Added:
3 months ago
Source:
Radcliffe CVRM
Following the primary analysis of the SELECT trial, which demonstrated that semaglutide reduces major adverse cardiovascular events, a new exploratory analysis suggests the treatment also significantly lowers the rate and duration of hospitalisations in patients with established cardiovascular disease (CVD) and overweight or obesity, but without diabetes.¹MethodologyThis prespecified exploratory…
View more
Added:
2 months ago
Source:
Radcliffe CVRM
With the rising prevalence of obesity and associated cardiovascular-kidney-metabolic (CKM) syndrome, indications for novel therapies are expanding. A new study has quantified the proportion of US adults who meet the approved indications for three key classes of CKM medications, revealing a substantial number are eligible for treatment.¹MethodologyThis cross-sectional study analysed data from…
View more
Author(s):
Sven M Francque
Added:
1 year ago
ECO 2024 — Prof Sven Francque (University of Antwerp, BE) joins us to talk about the new EASL-EASD-EASO Practice Guidelines for MAFLD.In this interview, Prof Francque highlights some of the unmet needs in people with MAFLD (formerly known as NAFLD). He then summarises the key highlights of the latest guidelines, including guidance on treatment options. He also discusses some of the challenges…
View more
Salvatore Carbone
Research Area(s) / Expertise:
Author